Anvisa approves regulations for biosimilars

Biosimilar medicines that are part of the standard

Anvisa approves regulations for biosimilars

At a meeting of the Collegiate Board of Directors, Anvisa (the National Health Surveillance Agency) approved the new regulations for registering biosimilar medicines. The regulation dispenses with some specific steps and studies, when technically feasible, promoting a transparent and predictable regulatory environment for the sector. Read more here

If you need more information on regulatory issues in the pharmaceutical industry and healthcare, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

I want to speak to a Specialist

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.

I want to speak to a Specialist